Edition:
United States

Stemline Therapeutics Inc (STML.OQ)

STML.OQ on NASDAQ Stock Exchange Capital Market

11.00USD
22 Sep 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$11.00
Open
$11.00
Day's High
$11.20
Day's Low
$10.85
Volume
64,983
Avg. Vol
52,232
52-wk High
$14.60
52-wk Low
$5.50

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.61 December 23 Sep 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 3 3
(2) OUTPERFORM 2 2 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.50 1.50 1.40 1.40

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-17 3 0.17 0.30 0.00 0.60
Quarter Ending Dec-17 3 0.17 0.30 0.00 2.60
Year Ending Dec-17 3 0.93 1.20 0.60 4.92
Year Ending Dec-18 4 35.59 74.70 2.10 18.23
Earnings (per share)
Quarter Ending Sep-17 3 -0.61 -0.60 -0.62 -0.44
Quarter Ending Dec-17 3 -0.63 -0.60 -0.68 -0.41
Year Ending Dec-17 3 -2.56 -2.52 -2.63 -2.01
Year Ending Dec-18 4 -0.99 0.50 -2.16 -1.09

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-17 0.20 0.30 0.10 49.65
Quarter Ending Mar-17 0.15 0.30 0.15 102.85
Quarter Ending Dec-16 0.23 0.30 0.07 29.50
Quarter Ending Sep-16 0.18 0.30 0.12 70.47
Quarter Ending Jun-16 0.17 0.24 0.07 39.99

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-17 0.17 0.17 0.17 0.16 0.60
Quarter Ending Dec-17 0.17 0.17 0.17 0.16 2.60
Year Ending Dec-17 0.93 0.93 0.93 0.78 4.92
Year Ending Dec-18 35.59 35.59 35.59 29.48 18.23

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-17 0 0 0 0
Quarter Ending Dec-17 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings